Two follow-up studies have uncovered that GP73 is highly expressed in prostate cancer tissues, which indicate that GP73 may not be an HCC-specific biomarker but potentially applicable for diagnosis of pan-cancers (32, 33). Here, GOLM1 is linked to hepatocellular carcinoma.